ATE275961T1 - Synthetische phosphopeptide zur behandlung von knochenerkrankheiten - Google Patents

Synthetische phosphopeptide zur behandlung von knochenerkrankheiten

Info

Publication number
ATE275961T1
ATE275961T1 AT97932409T AT97932409T ATE275961T1 AT E275961 T1 ATE275961 T1 AT E275961T1 AT 97932409 T AT97932409 T AT 97932409T AT 97932409 T AT97932409 T AT 97932409T AT E275961 T1 ATE275961 T1 AT E275961T1
Authority
AT
Austria
Prior art keywords
treatment
bone diseases
phosphopeptides
synthetic phosphopeptides
synthetic
Prior art date
Application number
AT97932409T
Other languages
English (en)
Inventor
Yoshinari Kumagai
Akira Otaka
Original Assignee
Acologix Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acologix Inc filed Critical Acologix Inc
Application granted granted Critical
Publication of ATE275961T1 publication Critical patent/ATE275961T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/16—Phosphorus containing

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Polyamides (AREA)
AT97932409T 1996-07-03 1997-06-30 Synthetische phosphopeptide zur behandlung von knochenerkrankheiten ATE275961T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/675,031 US5837674A (en) 1996-07-03 1996-07-03 Phosphopeptides and methods of treating bone diseases
PCT/US1997/011426 WO1998000156A1 (en) 1996-07-03 1997-06-30 Synthetic phosphopeptides for treating bone diseases

Publications (1)

Publication Number Publication Date
ATE275961T1 true ATE275961T1 (de) 2004-10-15

Family

ID=24708791

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97932409T ATE275961T1 (de) 1996-07-03 1997-06-30 Synthetische phosphopeptide zur behandlung von knochenerkrankheiten

Country Status (11)

Country Link
US (2) US5837674A (de)
EP (1) EP0938326B1 (de)
JP (2) JP2001503452A (de)
AT (1) ATE275961T1 (de)
AU (1) AU727675B2 (de)
CA (1) CA2258661C (de)
DE (1) DE69730725T2 (de)
DK (1) DK0938326T3 (de)
ES (1) ES2224260T3 (de)
PT (1) PT938326E (de)
WO (1) WO1998000156A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5837674A (en) * 1996-07-03 1998-11-17 Big Bear Bio, Inc. Phosphopeptides and methods of treating bone diseases
US20030118572A1 (en) * 1997-12-29 2003-06-26 Novozymes A/S Modified enzymes
WO1999060017A2 (en) * 1998-05-18 1999-11-25 University College London Human tumour-derived polypeptide hormone phosphatonin
US7022522B2 (en) 1998-11-13 2006-04-04 Limin Guan Macroporous polymer scaffold containing calcium phosphate particles
JP2003508446A (ja) * 1999-09-02 2003-03-04 アコロジックス インコーポレイテッド 血清リン酸レベルを低下させるための方法及び組成物
US7078021B2 (en) * 2000-08-16 2006-07-18 Acologix, Inc. Dental products comprising bone growth enhancing peptide
US6911425B2 (en) * 2000-08-16 2005-06-28 Acologix, Inc. Integrin binding motif containing peptides and methods of treating skeletal diseases
US6904123B2 (en) 2000-08-29 2005-06-07 Imaging Therapeutics, Inc. Methods and devices for quantitative analysis of x-ray images
US7545964B2 (en) 2000-08-29 2009-06-09 Imaging Therapeutics, Inc. Methods and devices for quantitative analysis of x-ray images
US7467892B2 (en) * 2000-08-29 2008-12-23 Imaging Therapeutics, Inc. Calibration devices and methods of use thereof
US8639009B2 (en) 2000-10-11 2014-01-28 Imatx, Inc. Methods and devices for evaluating and treating a bone condition based on x-ray image analysis
US7660453B2 (en) 2000-10-11 2010-02-09 Imaging Therapeutics, Inc. Methods and devices for analysis of x-ray images
CA2445746C (en) * 2001-04-30 2012-09-18 City Of Hope Chimeric immunoreceptor useful in treating human cancers
DE60233485D1 (de) 2001-05-25 2009-10-08 Imaging Therapeutics Inc Verfahren zur diagnose, behandlung und prävention von knochenverlust
AU2003221582A1 (en) * 2002-05-03 2003-11-17 Millenium Biologix Inc. Connective tissue stimulating peptides
US8600124B2 (en) 2004-09-16 2013-12-03 Imatx, Inc. System and method of predicting future fractures
US7840247B2 (en) * 2002-09-16 2010-11-23 Imatx, Inc. Methods of predicting musculoskeletal disease
US8965075B2 (en) * 2002-09-16 2015-02-24 Imatx, Inc. System and method for predicting future fractures
US7220406B2 (en) * 2002-10-22 2007-05-22 Genzyme Corporation Method for promoting bone formation
WO2004086972A2 (en) 2003-03-25 2004-10-14 Imaging Therapeutics, Inc. Methods for the compensation of imaging technique in the processing of radiographic images
US8290564B2 (en) 2003-09-19 2012-10-16 Imatx, Inc. Method for bone structure prognosis and simulated bone remodeling
EP1663002A4 (de) * 2003-09-19 2007-11-28 Imaging Therapeutics Inc Verfahren für die knochenstrukturprognose und simulierte knochenremodellierung
US20080058613A1 (en) * 2003-09-19 2008-03-06 Imaging Therapeutics, Inc. Method and System for Providing Fracture/No Fracture Classification
JP2008526871A (ja) * 2005-01-07 2008-07-24 アコロジックス インコーポレイティッド 歯周および歯の治療のためのペプチド製剤
US7622438B1 (en) 2005-07-18 2009-11-24 Acologix, Inc. Protein formulation for promoting hard tissue formation
AU2008209473B2 (en) * 2007-01-22 2012-10-25 Orthotrophix, Inc. A peptide composition and a method of promoting cartilage formation
US8939917B2 (en) 2009-02-13 2015-01-27 Imatx, Inc. Methods and devices for quantitative analysis of bone and cartilage
TWI382852B (zh) * 2009-12-22 2013-01-21 臺北醫學大學 一種口腔保健用磷酸鈣複合物及其製法與組合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5015A (en) * 1847-03-13 Mode of producing reciprocating and latkral motions
CA1315480C (en) * 1986-06-12 1993-03-30 Eric Charles Reynolds Phosphopeptides
US5015628A (en) * 1986-06-12 1991-05-14 The University Of Melbourne Anticariogenic phosphopeptides
JPH01285158A (ja) * 1988-05-12 1989-11-16 Itochu Shiryo Kk 家禽用飼料
US5051401A (en) * 1989-04-07 1991-09-24 University Of South Alabama Inhibition of mineral deposition by phosphorylated and related polyanionic peptides
US5837674A (en) * 1996-07-03 1998-11-17 Big Bear Bio, Inc. Phosphopeptides and methods of treating bone diseases

Also Published As

Publication number Publication date
AU3587197A (en) 1998-01-21
JP2004067687A (ja) 2004-03-04
AU727675B2 (en) 2000-12-21
CA2258661C (en) 2002-09-10
WO1998000156A1 (en) 1998-01-08
DK0938326T3 (da) 2005-01-03
DE69730725D1 (de) 2004-10-21
EP0938326B1 (de) 2004-09-15
PT938326E (pt) 2004-11-30
EP0938326A1 (de) 1999-09-01
US6306822B1 (en) 2001-10-23
ES2224260T3 (es) 2005-03-01
EP0938326A4 (de) 2002-07-03
JP2001503452A (ja) 2001-03-13
DE69730725T2 (de) 2006-02-23
CA2258661A1 (en) 1998-01-08
US5837674A (en) 1998-11-17

Similar Documents

Publication Publication Date Title
DE69730725D1 (de) Synthetische phosphopeptide zur behandlung von knochenerkrankheiten
DE69736183D1 (de) Verwendung von topiramat oder derivate davon zur herstellung eines arzneimittels zur behandlung von manisch-depressiven bipolaren störungen
ATE302599T1 (de) Zubereitungen und verfahren zur behandlung oder prävention von krankheiten der körperpassagewege
ATE271393T1 (de) Zusammensetzungen zur erhöhung des hautdurchtritts von arzneistoffen unter verwendung von permeationsbeschleunigern
DE69918687D1 (de) 4-phenylpiperidine zur behandlung von prutitischen hauterkrankungen
DE69631613D1 (de) Mit Verriegelungsmechanismus versehene Vorrichtung zur chirurgischen Behandlung von Gewebe
ATE185971T1 (de) Kombinationspräparat zur behandlung hypogonadaler männer sowie männern mit hypophysenerkrankungen
DE69328981D1 (de) Verfahren zur Behandlung von hyperproliferaktiven Gefässerkrankungen unter Verwendung von Rapamycin, eventuell in Kombination mit Mykophenolsäure
DE69934112D1 (de) Implantierbarer gewebeverschluss und system zur behandlung gastroösophagischen rückflusses
DE60137430D1 (de) Gewebeimplant zur wiederherstellung von knorpelgewebe
DE69838338D1 (de) Verwendung von antimykotica zur topischen behandlung von pilz-induzierten schleimhautentzündungen
DE69730604D1 (de) Oxadisäuren und verwandte verbindungen zur behandlung von hautstörungen
DE69734531D1 (de) Beeinflussung von nitrosativem und oxidativem stress zur behandlung einer krankheit
EP0709090A3 (de) Zusammensetzungen zur Behandlung von resistenten Tumoren
DE69929787D1 (de) Verfahren zur behandlung von neurologischen erkrankungen mit hilfe der bestimmung des bche genotyps
DE69405919D1 (de) Zusammensetzungen zur Behandlung von Keratinfasern
DE69638281D1 (de) Anti-Interleukin-9 Antikörper oder Anti-Interleukin-9 Rezeptor Antikörper zur Behandlung von bronchialem Hyperreaktionsvermögen
DE69314234D1 (de) Konservierte Polysiloxanemulsion zur Behandlung von Geweben
ATE246518T1 (de) Egr-1 zur herstellung eines medikamentes zur behandlung von wunden
DE69737067D1 (de) Vakzine zur behandlung von mycosen
ATE226071T1 (de) Antikonvulsive derivate zur behandlung von neuropathischem schmerz
DE69607559D1 (de) Verfahren zur Behandlung von Phenolteer
DE69805305D1 (de) Verwendung von phanquinon zur behandlung von alzheimer's krankheit
DE69936994D1 (de) Verfahren zur behandlung von okularen neovaskularen erkrankungen
DE69301750D1 (de) Verwendung von 1-Alpha,24(R)-Dihydroxy-22(E)-Dehydrovitamin-D3 zur Herstellung eines Arzneimittels zur Behandlung der Osteoporose

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0938326

Country of ref document: EP

REN Ceased due to non-payment of the annual fee